Current Edition

Upcoming Events

Advertisement

news

Pfizer forecasts $100B in sales, fueled by COVID-19 vaccine, pill

Dive Brief: Pfizer on Tuesday forecast that its revenue this year will grow to total between $98 billion and $102 billion, which, measured at the range's midpoint,...
Continue Reading →
news

Merck wins UK authorization to sell first COVID-19 pill

U.K. regulators have once again moved faster than the Food and Drug Administration to approve a new medicine for COVID-19. The UK's Medicines and Healthcare products ...
Continue Reading →
news

Merck agrees to license COVID-19 pill widely through pact with patent group

Merck's pill has the potential to alter the course of the pandemic. Earlier this month, the company and partner Ridgeback Biotherapeutics released data showing molnup...
Continue Reading →